Cancer

Cell-Free DNA Methylation Predicts Chemo Benefit in Bladder Cancer

Methylation patterns in cfDNA from blood samples can help predict which patients with a type of bladder cancer may benefit from chemotherapy.

Cancer

Delfi Diagnostics Enters into Research Agreement with Cancer Center

Delfi Diagnostics has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center's Biomarker Development Program.

Cancer

ASCO Clinical Practice Guideline Adds BCI to Guide Extended Endocrine Therapy Decisions

The ASCO has expanded the utility of BCI in its guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”

How AI Can Detect Cancer from Patient Data Securely

Apr 26, 2022 | Cancer, Diagnostic Technologies

A new way of using AI to predict cancer from patient data without putting personal information at risk has been developed.

Urine Test for Bladder Cancer Could Cut Need for Cystoscopies

Apr 25, 2022 | Unknown Origin & Other Cancer Types, Urinalysis & Toxicology

Researchers have developed a new urine test for bladder cancer, which could significantly cut the need for invasive cystoscopies.

AI Improves Precancerous Polyp Detection in Colorectal Cancer Screening

Apr 20, 2022 | Colorectal

AI reduced the rate at which precancerous polyps were missed in colorectal cancer screening by twofold, according to new research.

New tsRNA Found in Blood May Improve Liver Cancer Diagnosis

Apr 19, 2022 | Cancer

New data has shown that a tsRNA named tRF-Gln-TTG-006 in liver cancer patients’ serum may be a promising biomarker to detect liver cancer.

DCIS Test Identifies Patients in Need of Intensified Therapy

Apr 15, 2022 | Breast

This study validated the clinical utility of a DCIS test to predict recurrence risk and radiation therapy benefit in certain patients

New PCR Test Can Diagnose and Treat Oral Cancer

Apr 13, 2022 | Unknown Origin & Other Cancer Types

Researchers have developed a PCR test for mouth cancer, which only requires machines used in COVID testing and a technician to operate it.

Prostate Cancer Detection Improved by Accounting for Genetics that Cause PSA Level Variations

Apr 12, 2022 | Prostate

PSA screening for prostate cancer could be improved by accounting for genetic factors that cause PSA changes not associated with cancer.

Gene Deletion Behind Anomaly in Blood Cancer Cells

Apr 8, 2022 | Cancer

Research has provided more clues on the origins and progression of certain blood cancers, suggesting new ways to diagnose and treat leukemias.

Researchers Develop Model to Detect & Combat Lung Cancer Recurrence

Apr 8, 2022 | Lung Cancer

Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.

Guardant Health Streamlines Access to Cancer Test Portfolio Through New Partnership

Apr 7, 2022 | Cancer

Guardant Health partnered with Epic, a health record company, to integrate the oncology company’s portfolio of cancer tests with its services.

Scientists Identify Cancer Biomarkers in Breast Milk

Apr 4, 2022 | Breast

Proteins could one day allow breast cancer screenings to be done via blood test thanks to new biomarkers identified in breast milk.

Liquid Biopsy Tools Help Detect, Monitor Recurrent Breast Cancer

Mar 31, 2022 | Breast

Liquid biopsy performed on serum samples from breast cancer patients can provide increasingly accurate information on cancer progression.

NIH Awards Grant for Autofluorescence-Free Cytometry Development

Mar 28, 2022 | Flow Cytometry Instruments, Leukemia

Kinetic River has been awarded a Phase II SBIR grant for the development of an autofluorescence-free flow cytometry platform.

AI Software Spots Breast Cancer Metastases in Lymph Nodes

Mar 25, 2022 | Analytical Software Systems, Breast

Paige, has launched its Paige Breast Lymph Node, an AI software that helps detect if breast cancer has metastasized to lymph nodes.

Sema4 Expands Disparity Study on Precision Oncology Care for Underserved Communities

Mar 21, 2022 | Cancer

The study aims to enables access to comprehensive genetic and genomic testing for advanced cancer patients in underserved communities.

Category: Cancer

Cancer

Cancer

Cancer